The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 58,838 | 1,440,000 | SH | SOLE | 1,440,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 119,313 | 2,165,000 | SH | SOLE | 2,165,000 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 34,370 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 31,948 | 1,225,000 | SH | SOLE | 1,225,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 169,520 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
BEAM THERAPEUTICS INC | COM | 07373V105 | 105,390 | 818,820 | SH | SOLE | 818,820 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 51,479 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
BIOLIFE SOLUTIONS INC | COM NEW | 09062W204 | 331,159 | 7,440,107 | SH | SOLE | 7,440,107 | 0 | 0 | ||
BERKELEY LTS INC | COM | 084310101 | 8,962 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 136,338 | 1,550,000 | SH | SOLE | 1,550,000 | 0 | 0 | ||
CAREDX INC | COM | 14167L103 | 109,214 | 1,193,335 | SH | SOLE | 1,193,335 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 98,118 | 4,330,000 | SH | SOLE | 4,330,000 | 0 | 0 | ||
CONSTELLATION PHARMCETICLS I | COM | 210373106 | 45,326 | 1,341,000 | SH | SOLE | 1,341,000 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 43,132 | 266,430 | SH | SOLE | 266,430 | 0 | 0 | ||
DERMTECH INC | COM | 24984K105 | 72,540 | 1,745,000 | SH | SOLE | 1,745,000 | 0 | 0 | ||
DENALI THERAPEUTICS INC | COM | 24823R105 | 126,288 | 1,610,000 | SH | SOLE | 1,610,000 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 293,395 | 2,360,186 | SH | SOLE | 2,360,186 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 295,086 | 3,400,000 | SH | SOLE | 3,400,000 | 0 | 0 | ||
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 26,863 | 1,115,555 | SH | SOLE | 1,115,555 | 0 | 0 | ||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 2,307 | 216,216 | SH | SOLE | 216,216 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 12,099 | 1,154,476 | SH | SOLE | 1,154,476 | 0 | 0 | ||
GENERATION BIO CO | COM | 37148K100 | 43,342 | 1,611,214 | SH | SOLE | 1,611,214 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 45,876 | 1,310,000 | SH | SOLE | 1,310,000 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 13,973 | 583,436 | SH | SOLE | 583,436 | 0 | 0 | ||
908 DEVICES INC | COM | 65443P102 | 15,752 | 406,502 | SH | SOLE | 406,502 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 32,724 | 3,346,034 | SH | SOLE | 3,346,034 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 411,630 | 12,203,669 | SH | SOLE | 12,203,669 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 10,641 | 601,515 | SH | SOLE | 601,515 | 0 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 174,850 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 123,493 | 3,375,058 | SH | SOLE | 3,375,058 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 73,161 | 2,305,000 | SH | SOLE | 2,305,000 | 0 | 0 | ||
SEER INC | COM CL A | 81578P106 | 4,917 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
SANGAMO THERAPEUTICS INC | COM | 800677106 | 6,584 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 20,604 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 68,800 | 885,000 | SH | SOLE | 885,000 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 4,039 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
TURNING POINT THERAPEUTICS I | COM | 90041T108 | 5,852 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
TWIST BIOSCIENCE CORP | COM | 90184D100 | 133,250 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 33,628 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
DECIBEL THERAPEUTICS INC | COM | 24343R106 | 10,074 | 1,171,421 | SH | SOLE | 1,171,421 | 0 | 0 | ||
SANA BIOTECHNOLOGY INC | COM | 799566104 | 1,180 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 14,116 | 3,215,434 | SH | SOLE | 3,215,434 | 0 | 0 | ||
CLOVER HEALTH INVESTMENTS CO | COM CL A | 18914F103 | 9,677 | 726,511 | SH | SOLE | 726,511 | 0 | 0 | ||
ALPHA TEKNOVA INC | COM | 02080L102 | 7,119 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
AMYRIS INC | COM NEW | 03236M200 | 49,110 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 94,075 | 3,206,380 | SH | SOLE | 3,206,380 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 21,812 | 960,883 | SH | SOLE | 960,883 | 0 | 0 | ||
RECURSION PHARMACEUTICALS IN | CL A | 75629V104 | 20,008 | 548,156 | SH | SOLE | 548,156 | 0 | 0 | ||
SINGULAR GENOMICS SYSTEMS IN | COM | 82933R100 | 74,000 | 2,692,870 | SH | SOLE | 2,692,870 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 183,050 | 3,038,167 | SH | SOLE | 3,038,167 | 0 | 0 | ||
ZYMERGEN INC | COM | 98985X100 | 1,200 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 5,050 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
23ANDME HOLDING CO | CLASS A COM | 90138Q108 | 32,048 | 2,741,457 | SH | SOLE | 2,741,457 | 0 | 0 | ||
NEOGENOMICS INC | COM NEW | 64049M209 | 22,083 | 488,889 | SH | SOLE | 488,889 | 0 | 0 |